Axxess Pharma Inc. Anticipates Additional $700,000 in Annual Sales From Pre-Natal, Non-Constipating Multi-Vitamin Triferrex PN
August 26 2010 - 7:00AM
Marketwired
Axxess Pharma Inc. (PINKSHEETS: AXXE), a pharmaceutical company
specializing in the marketing and distribution of both prescription
and non-prescription medical products, is pleased to announce they
anticipate generating an additional $700,000 in annual sales from
their pre-natal, non-constipating multi-vitamin Triferrex PN.
Pre-natal multi-vitamins are a critical source of nutrients for
pregnant women.
Healthcare providers usually advise women to take prenatal
multi-vitamin supplements prior to, during, and after pregnancy
(postpartum). However, upon taking that advice, many pregnant women
struggle with taking the supplement and battle adverse effects such
as constipation or other discomforts. When constipation sets in,
pregnant women find it tough to continue taking the multi-vitamin
thus putting their health and the babies' health in jeopardy.
Triferrex PN helps eliminate these problems by providing the
careful balance of required nutrients while preventing
constipation.
"We look forward to releasing a high demand, pre-natal
multi-vitamin Triferrex PN. This product will be launched shortly
and is anticipated to generate an additional $700,000 in annual
sales. Our current Triferrex multi-vitamin for both men and women
has already generated $1.3 million in revenues for 2009. With the
rollout of Triferrex PN, we feel confident in surpassing $2.3
million in annual revenue from our Triferrex line," stated Gerald
Sequeira, President/CEO.
For more information, please contact Investor Relations at (973)
351-3868.
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a specialty pharmaceutical company that
focuses on the marketing of dermatological, therapeutic
nutritionals, pain management and diagnostic products in Canada and
abroad since 1997. Axxess owns 22 established pharmaceutical
prescription products that have proven sales in Canada and
internationally. The company has an experienced management team and
field sales force to market products nationally to hospitals and
retail pharmacies as well as specialized practice areas including
Dermatology and Nephrology, Neurology and Urology.
Safe Harbor
Statements about the Company's future expectations and all other
statements in this press release other than historical facts, are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities
Litigation Reform Act of 1995. The Company intends that such
forward-looking statements be subject to the safe harbors created
thereby.
The above information contains information relating to the
Company that is based on the beliefs of the Company and/or its
management, as well as assumptions made by any information
currently available to the Company or its management. When used in
this document, the words "anticipate," "estimate," "expect,"
"intend," "plans," "projects," and similar expressions, as they
relate to the Company or its management, are intended to identify
forward-looking statements. Such statements reflect the current
view of the Company regarding future events and are subject to
certain risks, uncertainties and assumptions, including the risks
and uncertainties noted. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
to be incorrect, actual results may vary materially from those
described herein as anticipated, believed, estimated, expected,
intended or projected. In each instance, forward-looking
information should be considered in light of the accompanying
meaningful cautionary statements herein. Factors that could cause
results to differ include, but are not limited to, successful
performance of internal plans, the impact of competitive services
and pricing and general economic risks and uncertainties.
Contact: Taylor Capitol, Inc. Investor Relations Stephen Taylor
973-351-3868 Info@TheStockAlerts.com www.TheStockAlerts.com
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allstar Health Brands (PK) (USOTC:ALST)
Historical Stock Chart
From Jul 2023 to Jul 2024